企業プロフィール
ADC Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- ADCT
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- Switzerland
株価パフォーマンス
1.10 USD (+8.91%)
終値
最終更新: 2026年8月17日
403M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ADCT closed up 8.91% at $1.10. No new same-company headline was identified in the current news window.
企業概要
事業概要
ADC Therapeutics is an oncology company focused on antibody-drug conjugates for cancer. Its platform is built around delivering cytotoxic payloads directly into tumor cells.
所在地とセクター分類
Headquartered in Switzerland and listed on NASDAQ as an ADR, ADC Therapeutics has a global oncology-biotech profile.
ビジネスモデルの特徴
The company depends on clinical data, commercial execution, and the ability to sustain a differentiated ADC franchise.
バイオ業界での位置付け
ADC Therapeutics is a classic oncology catalyst name whose stock reacts to readouts and product execution.
今後のカタリスト
- ADC Therapeutics’ catalysts are ZYNLONTA execution, employee-inducement grants / pipeline updates, and any commercial progress that proves the franchise can keep stabilizing. The market will focus on whether the company can turn a niche ADC into a more durable asset.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。